Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$3.03 USD
-0.03 (-0.98%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $2.92 -0.11 (-3.63%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
03/06/2025
Time: AMC |
12/2024 | $0.15 | 0.00% |
Earnings Summary
For their last quarter, Puma Biotechnology (PBYI) reported earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.35 per share. This reflects a positive earnings surprise of 28.57%. Look out for PBYI's next earnings release expected on March 06, 2025. For the next earning release, we expect the company to report earnings of $0.15 per share, reflecting a year-over-year increase of 105.88%.
Earnings History
Price & Consensus
Zacks News for PBYI
Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected
PBYI: What are Zacks experts saying now?
Zacks Private Portfolio Services